Cardiovascular Disease and Type 1 Diabetes
Purpose of the Workshop
Cardiovascular disease remains the leading cause of death for people with type 1 diabetes, despite improvements in the control of glucose, blood pressure, and lipid levels. The pathophysiology, risk factors, and clinical course of cardiovascular disease in type 1 diabetes have features that are different from those for cardiovascular disease in people with type 2 diabetes or without diabetes, yet most of the clinical recommendations for people with type 1 diabetes are based on studies of these other populations. The goals of the workshop are the following:
- Review the pathophysiology of atherosclerosis and myocardial infarction in people with type 1 diabetes.
- Compare and contrast risk factors for cardiovascular disease that are general, diabetes-specific, and type 1 diabetes-specific.
- Review the clinical presentation and course for acute coronary syndrome and stroke in type 1 diabetes.
- Discuss and prioritize research questions for cardiovascular disease and type 1 diabetes.
- Review and discuss the approaches and resources needed to address the high-priority research questions.
Workshop Organizing Committee
Robert H. Eckel, M.D., University of Colorado (Co-chair)
David M. Nathan, M.D., Massachusetts General Hospital (Co-chair)
Judith E. Fradkin, M.D., NIDDK
Larissa Aviles-Santa, M.D., M.P.H., NHLBI
Denise Bonds, M.D., M.P.H., NHLBI
Teresa L.Z. Jones, M.D., NIDDK
Barbara Linder, M.D., Ph.D., NIDDK
Peter J. Savage, M.D., NIDDK